Thomas Meier

Thomas Meier, Ph.D. is a Professor in the Department of Cell Biology at Albert Einstein College of Medicine. His research spans molecular and cellular biology with a focus on nuclear organization, RNA processing, and their connections to human disease and reproductive biology.

His educational background includes a Ph.D. (though specific institution not mentioned in text), with research activity dating back to 1984. His work demonstrates deep expertise in nucleolar function, Cajal bodies, and ribonucleoprotein complexes through a substantial publication record of 53 research outputs.

Meier's research interests focus on the molecular mechanisms of RNA modification, ribonucleoprotein biogenesis, and nucleolar function. His work connects fundamental cellular processes to human conditions including dyskeratosis congenita and endometrial receptivity. His fingerprint shows strong emphasis on Ribonucleoprotein (100%), RNA (66%), Cajal Body (58%), Nopp140 (54%), Nucleolus (51%), Dyskeratosis Congenita (33%), and Endometrium (30%) research areas.

His publication trends reveal consistent work on RNA modification mechanisms, particularly focusing on H/ACA ribonucleoproteins, nucleolar channel systems, and their roles in both basic cellular functions and clinical applications in reproductive medicine. Recent work (2021-2025) shows continued innovation in understanding RNA processing and its implications for human health.

Meier has served as Principal Investigator on multiple significant research grants, including:

• Endometrial Receptivity (2018-2020)
• Cellular impact of X-linked dyskeratosis congenita (2017-2021)
• Biogenesis of H/ACA Ribonucleoproteins (2012-2016)
• Molecular Mechanism of Dyskeratosis Congenita (2004-2010)
• Nuclear-Cytoplasmic Transport (1995-1998)

His laboratory work focuses on the molecular mechanisms of ribonucleoprotein assembly, with particular emphasis on dyskeratosis congenita pathogenesis and endometrial biology. The research bridges basic science of RNA modification with clinical applications in reproductive medicine and genetic disorders.